Core Insights - Best Buy Co., Inc. is a leading retailer in consumer electronics, appliances, and entertainment products, operating in the U.S., Canada, and Mexico, competing with major retailers like Amazon, Walmart, and Target [1] Financial Performance - Best Buy's fourth-quarter earnings report revealed net earnings of $541 million, a significant increase from $117 million the previous year [3][5] - Revenue for the quarter was $13.8 billion, slightly below analyst expectations of $13.9 billion and down about 1% from the previous year [3] - Earnings per share reached $2.61, exceeding estimates, driven by growth in the Ads and Marketplace segments [4][5] Future Projections - The company projects fiscal year 2027 revenues between $41.2 billion and $42.1 billion, with expected margin increases from the Ads and Marketplace sectors [4][5] - Following the earnings announcement, the stock experienced a 7% increase, indicating positive market reaction [3] Stock Analysis - Michael Baker from D.A. Davidson set a price target of $78 for Best Buy, suggesting a potential upside of approximately 18.07% from the current trading price of $66.06 [2][5] - The stock's current price is $65.49, reflecting a decrease of 2.82% or $1.90 [2]

Israel’s prime minister has spent much of his long career lecturing American presidents on the need to confront Iran. Now he is being set up as the fall guy should the war descend into debacle https://t.co/bXTLQoS8SX ...

New York, New York--(Newsfile Corp. - March 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CoreWeave, Inc. (NASDAQ: CRWV) between March 28, 2025 and December 15, 2025, both dates inclusive (the "Class Period"), of the important March 13, 2026 lead plaintiff deadline.SO WHAT: If you purchased CoreWeave securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arra ...

Eight New Hospitality Clients Drive Upward Revision to 2026 Hong Kong Revenue EstimateSingapore, March 06, 2026 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group” or the “Company”), a global leader in on-demand workforce solutions and integrated facilities management (IFM), today announced a significant expansion of its operational footprint in Hong Kong. Following the execution of eight new multi-year service agreements, building upon the 12 hotel partnerships announced on January 21, ...

OAKLAND, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2025. Company Update Subsequent to the end of the fourth quarter 2025, the Company completed the acquisition of US Salt Parent Holdings, LLC and its subsidiaries (together, "US Salt"), marking a pivotal milestone in ContextLogic's evolution into a business ownership platform. ...

Exhibit 99.1 Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results Completed pre-IND meeting following MGX-001 preclinical data demonstrating curative FVIII activity in non- human primates (NHPs) and remains on track for global regulatory submission including investigational new drug application ("IND") in 4Q 2026 Announced corporate name change to Metagenomi Therapeutics, Inc. to reflect Company's strategic evolution $160.8 million in cash, cash equivalents and available-for ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission file number 001-35713 WHEELER REAL ESTATE INVESTMENT TRUST, INC. (Exact Name of Registrant as Specified in Its Charter) Securities registere ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission file number 001-35713 WHEELER REAL ESTATE INVESTMENT TRUST, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Juri ...

OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - Q4 revenue of $32.2 million WALTHAM, MA. – March 5, 2026 – OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the fourth quarter and full year ended December 31, 2025. Financial Highlights Stephen L. Silvestro, OptimizeRx CEO commented, "We delivered a stro ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File Number 001-42001 Contineum Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 27-1467257 Sta ...